0000902664-24-000903.txt : 20240201
0000902664-24-000903.hdr.sgml : 20240201
20240201164758
ACCESSION NUMBER: 0000902664-24-000903
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240130
FILED AS OF DATE: 20240201
DATE AS OF CHANGE: 20240201
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HILLHOUSE INVESTMENT MANAGEMENT, LTD.
CENTRAL INDEX KEY: 0001510589
ORGANIZATION NAME:
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41929
FILM NUMBER: 24587637
BUSINESS ADDRESS:
STREET 1: OFFICE #122, WINDWARD 3 BUILDING
STREET 2: REGATTA OFFICE PARK, WEST BAY ROAD
CITY: GRAND CAYMAN
STATE: E9
ZIP: KY1-9006
BUSINESS PHONE: 345-749-8642
MAIL ADDRESS:
STREET 1: OFFICE #122, WINDWARD 3 BUILDING
STREET 2: REGATTA OFFICE PARK, WEST BAY ROAD
CITY: GRAND CAYMAN
STATE: E9
ZIP: KY1-9006
FORMER NAME:
FORMER CONFORMED NAME: HILLHOUSE CAPITAL MANAGEMENT, LTD.
DATE OF NAME CHANGE: 20190510
FORMER NAME:
FORMER CONFORMED NAME: Hillhouse Capital Management, Ltd.
DATE OF NAME CHANGE: 20150109
FORMER NAME:
FORMER CONFORMED NAME: Hillhouse Capital Management Pte. Ltd.
DATE OF NAME CHANGE: 20150108
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HHLR ADVISORS, LTD.
CENTRAL INDEX KEY: 0001762304
ORGANIZATION NAME:
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41929
FILM NUMBER: 24587636
BUSINESS ADDRESS:
STREET 1: OFFICE #122, WINDWARD 3 BUILDING
STREET 2: REGATTA OFFICE PARK, WEST BAY ROAD
CITY: GRAND CAYMAN
STATE: E9
ZIP: KY1-9006
BUSINESS PHONE: (345) 749-8643
MAIL ADDRESS:
STREET 1: OFFICE #122, WINDWARD 3 BUILDING
STREET 2: REGATTA OFFICE PARK, WEST BAY ROAD
CITY: GRAND CAYMAN
STATE: E9
ZIP: KY1-9006
FORMER NAME:
FORMER CONFORMED NAME: HILLHOUSE CAPITAL ADVISORS, LTD.
DATE OF NAME CHANGE: 20190510
FORMER NAME:
FORMER CONFORMED NAME: Hillhouse Capital Advisors, Ltd.
DATE OF NAME CHANGE: 20181218
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ArriVent Biopharma, Inc.
CENTRAL INDEX KEY: 0001868279
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 18 CAMPUS BLVD.
STREET 2: SUITE 100
CITY: NEWTOWN SQUARE
STATE: PA
ZIP: 19073-3269
BUSINESS PHONE: 240-780-6356
MAIL ADDRESS:
STREET 1: 18 CAMPUS BLVD.
STREET 2: SUITE 100
CITY: NEWTOWN SQUARE
STATE: PA
ZIP: 19073-3269
4
1
ownership.xml
X0508
4
2024-01-30
0
0001868279
ArriVent Biopharma, Inc.
AVBP
0001510589
HILLHOUSE INVESTMENT MANAGEMENT, LTD.
OFFICE #122, WINDWARD 3 BUILDING
REGATTA OFFICE PARK, WEST BAY ROAD
GRAND CAYMAN
E9
KY1-9006
CAYMAN ISLANDS
0
0
1
0
0001762304
HHLR ADVISORS, LTD.
OFFICE #122, WINDWARD 3 BUILDING
REGATTA OFFICE PARK, WEST BAY ROAD
GRAND CAYMAN
E9
KY1-9006
CAYMAN ISLANDS
0
0
1
0
0
Common Stock
2024-01-30
4
C
0
3616041
A
3616041
I
See footnotes
Common Stock
2024-01-30
4
C
0
313076
A
3929117
I
See footnotes
Common Stock
2024-01-30
4
P
0
555555
18.00
A
4484672
I
See footnotes
Series A Preferred Stock
2024-01-30
4
C
0
55000000
0
D
Common Stock
3616041
0
I
See footnotes
Series B Preferred Stock
2024-01-30
4
C
0
4761903
0
D
Common Stock
313076
0
I
See footnotes
Immediately prior to the closing of the Issuer's initial public offering, each share of Series A Preferred Stock and Series B Preferred Stock converted into shares of common stock on a 15.21-for-1 basis.
The securities reported herein are held by VSUM VI Holdings Limited ("VSUM VI") and VSUM VIII Holdings Limited ("VSUM VIII"). VSUM VI is a wholly owned subsidiary of Hillhouse Venture Fund V, L.P. ("Hillhouse Venture V") and VSUM VIII is a wholly owned subsidiary of Hillhouse Healthcare Fund, L.P. ("Hillhouse Healthcare"). HIM (as defined below) acts as the sole management company of each of Hillhouse Venture V and Hillhouse Healthcare.
The securities reported herein are held by VSUM VIII and ARVT Holdings Limited ("ARVT"). VSUM VIII is a wholly owned subsidiary of Hillhouse Healthcare and ARVT is a wholly owned subsidiary of Hillhouse Venture Fund VI, L.P. ("Hillhouse Venture VI"). HIM acts as the sole management company of each of Hillhouse Healthcare and Hillhouse Venture VI.
The securities reported herein are held by HHLR Fund, L.P., an exempted Cayman Islands limited partnership ("HHLR Fund"). HHLR (as defined below) acts as the sole management company of HHLR Fund.
This statement is filed by (i) Hillhouse Investment Management, Ltd., an exempted Cayman Islands company ("HIM") and (ii) HHLR Advisors, Ltd., an exempted Cayman Islands company ("HHLR"). The foregoing persons are hereinafter sometimes each referred to as a "Reporting Person" and collectively referred to as the "Reporting Persons." HIM and HHLR are under common control and share certain policies, personnel and resources. Accordingly, HIM and HHLR are filing this Form 4 jointly.
The filing of this statement shall not be deemed an admission that each of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any.
Hillhouse Investment Management, Ltd., by /s/ Audrey Woon, Chief Compliance Officer
2024-02-01
HHLR Advisors, Ltd. /s/ Audrey Woon, Chief Compliance Officer
2024-02-01